Overview

A key corporate objective is to maximize the number of products being developed with the alphavaccine platform system, creating as many commercial opportunities as possible, and minimizing the risk associated with any one product program.

To translate scientific discovery into commercial success requires combining great science with effective development and commercialization all while satisfying stringent regulatory requirements. Our highly experienced vaccine development team brings substantial collective experience in process development, analytical methods, regulatory affairs, compliance, technology transfer, and manufacturing, and is supplemented by the resources and support of our public sector and industry partners to establish an extensive product pipeline.